269 related articles for article (PubMed ID: 22951308)
1. Application of IL-2 therapy to target T regulatory cell function.
Shevach EM
Trends Immunol; 2012 Dec; 33(12):626-32. PubMed ID: 22951308
[TBL] [Abstract][Full Text] [Related]
2. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
3. Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species.
Karakus U; Sahin D; Mittl PRE; Mooij P; Koopman G; Boyman O
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328333
[TBL] [Abstract][Full Text] [Related]
4. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.
Hayes ET; Hagan CE; Khoryati L; Gavin MA; Campbell DJ
J Immunol; 2020 Nov; 205(10):2667-2678. PubMed ID: 33055282
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases.
Xu L; Song X; Su L; Zheng Y; Li R; Sun J
Int Immunopharmacol; 2019 Jul; 72():322-329. PubMed ID: 31005777
[TBL] [Abstract][Full Text] [Related]
7. Low-dose interleukin-2 promotes STAT-5 phosphorylation, T
Jeffery HC; Jeffery LE; Lutz P; Corrigan M; Webb GJ; Hirschfield GM; Adams DH; Oo YH
Clin Exp Immunol; 2017 Jun; 188(3):394-411. PubMed ID: 28176332
[TBL] [Abstract][Full Text] [Related]
8. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 and interleukin 10 function synergistically to promote CD8
Li X; Lu P; Li B; Zhang W; Yang R; Chu Y; Luo K
Int J Biochem Cell Biol; 2017 Jun; 87():1-7. PubMed ID: 28274688
[TBL] [Abstract][Full Text] [Related]
10. IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.
Nakamura S; Suzuki M; Sugimoto A; Tsuji-Takayama K; Yamamoto M; Otani T; Inoue T; Harashima A; Okochi A; Motoda R; Yamasaki F; Orita K; Kibata M
Exp Hematol; 2007 Feb; 35(2):287-96. PubMed ID: 17258077
[TBL] [Abstract][Full Text] [Related]
11. Revisiting IL-2: Biology and therapeutic prospects.
Abbas AK; Trotta E; R Simeonov D; Marson A; Bluestone JA
Sci Immunol; 2018 Jul; 3(25):. PubMed ID: 29980618
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis.
McNally A; Hill GR; Sparwasser T; Thomas R; Steptoe RJ
Proc Natl Acad Sci U S A; 2011 May; 108(18):7529-34. PubMed ID: 21502514
[TBL] [Abstract][Full Text] [Related]
13. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
15. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
[TBL] [Abstract][Full Text] [Related]
16. IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.
Yu P; Bamford RN; Waldmann TA
Eur J Immunol; 2014 Nov; 44(11):3330-41. PubMed ID: 25142300
[TBL] [Abstract][Full Text] [Related]
17. Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins.
Ghelani A; Bates D; Conner K; Wu MZ; Lu J; Hu YL; Li CM; Chaudhry A; Sohn SJ
Front Immunol; 2020; 11():1106. PubMed ID: 32582190
[TBL] [Abstract][Full Text] [Related]
18. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8
Kato H; Perl A
Front Immunol; 2021; 12():635531. PubMed ID: 33763079
[TBL] [Abstract][Full Text] [Related]
19. Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
Peraino JS; Zhang H; Rajasekera PV; Wei M; Madsen JC; Sachs DH; Huang CA; Wang Z
J Immunol Methods; 2014 Mar; 405():57-66. PubMed ID: 24462799
[TBL] [Abstract][Full Text] [Related]
20. Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells.
Dai Z; Zhang S; Xie Q; Wu S; Su J; Li S; Xu Y; Li XC
Am J Transplant; 2014 Jan; 14(1):39-48. PubMed ID: 24219162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
